Novel crystalline forms of a vegf-r inhibitor

The present invention relates to novel crystalline polymorphic and amorphous form of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic for...

Full description

Saved in:
Bibliographic Details
Main Authors MCLAUGHLIN, ROBERT WILLIAM, CAMPETA, ANTHONY MICHAEL, CHEKAL, BRIAN PATRICK, SINGER, ROBERT ALAN
Format Patent
LanguageChinese
English
Published 21.04.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel crystalline polymorphic and amorphous form of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one polymorphic form and to the therapeutic or prophylactic use of such polymorphic forms and compositions.
Bibliography:Application Number: TW200897112383